Comparative study on altered hepatic metabolism of CYP3A substrates in rats with glycerol-induced acute renal failure

Biopharmaceutics and Drug Disposition

Volumn 33, Issue 1, 2012, Pages 22-29

  Kusaba, Jun Ichi ^a   Kajikawa, Noriko ^a   Kawasaki, Hiromu ^a   Kurosaki, Yuji ^a   Aiba, Tetsuya ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Acute renal failure; Hepatic drug metabolism; Midazolam; Nifedipine; Rifabutin

Indexed keywords

CYTOCHROME P450 3A; GLYCEROL; MIDAZOLAM; NIFEDIPINE; RIFABUTIN;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG LIVER LEVEL; DRUG METABOLISM; LIVER METABOLISM; LIVER MICROSOME; MALE; MICHAELIS MENTEN KINETICS; NONHUMAN; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ACUTE KIDNEY INJURY; ANIMALS; CYTOCHROME P-450 CYP3A; GLYCEROL; MALE; MICROSOMES, LIVER; MIDAZOLAM; NIFEDIPINE; RATS; RATS, WISTAR; RIFABUTIN;

EID: 84857994282     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.1774     Document Type: Article

References (40)

1. Molander L, Hansson A, Lunell E, Alainentalo L, Hoffmann M, Larsson R. Pharmacokinetics of nicotine in kidney failure. Clin Pharmacol Ther 2000; 68: 250-260.
2. Muirhead GJ, Wilner K, Colburn W, Haug-Pihale G, Rouviex B. The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil. Br J Clin Pharmacol 2002; 53: 21S-30S.
3. MacKichan JJ. Influence of protein binding and use of unbound (free) drug concentrations. In Applied Pharmacokinetics and Pharmacodynamics, Burton ME, Shaw LM, Schentag JJ, Evans WE (eds). Lippincott Williams & Wilkins: Baltimore, 2006; 82-120.
4. Izuwa Y, Kusaba J-I, Horiuchi M, Aiba T, Kawasaki H, Kurosaki Y. Comparative study of increased plasma quinidine concentration in rats with glycerol- and cisplatin-induced acute renal failure. Drug Metab Pharmacokinet 2009; 24: 451-457.
5. Leblond F, Guévin C, Demers C, Pellerin I, Gascon- Barré M, Pichette V. Downregulation of hepatic cytochrome P450 in chronic renal failure. J Am Soc Nephrol 2001; 12: 326-332. (Pubitemid 32116374)
6. Lee MG, Lee JH, Oh JM. Pharmacokinetic changes of drugs in rat model of acute renal failure induced by uranyl nitrate: correlation between drug metabolism and hepatic microsomal cytochrome P450 isozymes. Curr Clin Pharmacol 2006; 1: 193-205.
7. Masubuchi Y, Kawasaki M, Horie T. Downregulation of hepatic cytochrome P450 enzymes associated with cisplatin-induced acute renal failure in male rats. Arch Toxicol 2006; 80: 347-353. (Pubitemid 43725218)
8. Sun H, Huang Y, Frassetto L, Benet LZ. Effects of uremic toxins on hepatic uptake and metabolism of erythromycin. Drug Metab Dispos 2004; 32: 1239-1246. (Pubitemid 39410907)
9. Hanada K, Ogawa R, Son K, et al. Effects of indoxylsulfate on the in vitro hepatic metabolism of various compounds using human liver microsomes and hepatocytes. Nephron Physiol 2006; 103: 179-186.
10. Lee DY, Jung YS, Shin HS, Lee I, Kim YC, Lee MG. Faster clearance of omeprazole in rats with acute renal failure induced by uranyl nitrate: contribution of increased expression of hepatic cytochrome P450 (CYP) 3A1 and intestinal CYP1A and 3A subfamilies. J Pharm Pharmacol 2008; 60: 843-851. (Pubitemid 351914022)
11. Choi YH, Lee YS, Kim TK, Lee BY, Lee MG. Faster clearance of mirodenafil in rats with acute renal failure induced by uranyl nitrate: contribution of increased protein expression of hepatic CYP3A1 and intestinal CYP1A1 and 3A1/2. J Pharm Pharmacol 2009; 61: 1325-1332.
12. Eeckhoudt SL, Horsmans Y, Verbeeck RK. Differential induction of midazolam metabolism in the small intestine and liver by oral and intravenous dexamethasone pretreatment in rat. Xenobiotica 2002; 32: 975-984. (Pubitemid 35347005)
13. Kobayashi K, Urashima K, Shimada N, Chiba K. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochem Pharmacol 2002; 63: 889-896. (Pubitemid 34243002)
14. Kotegawa T, Laurijssens BE, Von Moltke LL, et al. In vitro, pharmacokinetic, and pharmacodynamic interactions of ketoconazole and midazolam in the rat. J Pharmacol Exp Ther 2002; 302: 1228-1237. (Pubitemid 34920247)
15. Carr B, Norcross R, Fang Y, et al. Characterization of the rhesus monkey CYP3A64 enzyme: species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymes. Drug Metab Dispos 2006; 34: 1703-1712. (Pubitemid 44427473)
16. Uesawa Y, Mohri K. Effects of cranberry juice on nifedipine pharmacokinetics in rats. J Pharm Pharmacol 2006; 58: 1067-1072. (Pubitemid 44213639)
17. Koudriakova T, Iatsimirskaia E, Tulebaev S, et al. In vivo disposition and metabolism by liver and enterocyte microsomes of the antitubercular drug rifabutin in rats. J Pharmacol Exp Ther 1996; 279: 1300-1309. (Pubitemid 27166778)
18. Iatsimirskaia E, Tulebaev S, Storozhuk E, et al. Metabolism of rifabutin in human enterocyte and liver microsomes: kinetic parameters, identification of enzyme systems, and drug interactions with macrolides and antifungal agents. Clin Pharmacol Ther 1997; 61: 554-562. (Pubitemid 27261759)
19. Aiba T, Yoshinaga M, Ishida K, Takehara Y, Hashimoto Y. Intestinal expression and metabolic activity of the CYP3A subfamily in female rats. Biol Pharm Bull 2005; 28: 311-315. (Pubitemid 40880015)
20. Sakae R, Ishikawa A, Niso T, et al. Decreased lithium disposition to cerebrospinal fluid in rats with glycerol-induced acute renal failure. Pharm Res 2008; 25: 2243-2249.
21. Aiba T, Takehara Y, Okuno M, Hashimoto Y. Poor correlation between intestinal and hepatic metabolic rates of CYP3A4 substrates in rats. Pharm Res 2003; 20: 745-748. (Pubitemid 36515306)
22. Easterbrook J, Lu C, Sakai Y, Li AP. Effects of organic solvents on the activities of cytochrome P450 isoforms, UDP-dependent glucuronyl transferase, and phenol sulfotransferase in human hepatocytes. Drug Metab Dispos 2001; 29: 141-144. (Pubitemid 32112927)
23. Moon YJ, Lee AK, Chung HC, et al. Effects of acute renal failure on the pharmacokinetics of chlorzoxazone in rats. Drug Metab Dispos 2003; 31: 776-784. (Pubitemid 36617668)
24. Ohishi N, Imaoka S, Funae Y. Changes in content of P450 isozymes in hepatic and renal microsomes of the male rat treated with cis- diamminedichloroplatinum. Xenobiotica 1994; 24: 873-880. (Pubitemid 24311312)
25. Debri K, Boobis AR, Davies DS, Edwards RJ. Distribution and induction of CYP3A1 and CYP3A2 in rat liver and extrahepatic tissues. Biochem Pharmacol 1995; 50: 2047-2056. (Pubitemid 26089930)
26. Wright MC, Edwards RJ, Pimenta M, et al. Developmental changes in the constitutive and inducible expression of cytochrome P450 3A2. Biochem Pharmacol 1997; 54: 841-846. (Pubitemid 27404686)
27. Konno Y, Sekimoto M, Nemoto K, Degawa M. Sex difference in induction of hepatic CYP2B and CYP3A subfamily enzymes by nicardipine and nifedipine in rats. Toxicol Appl Pharmacol 2004; 196: 20-28. (Pubitemid 38393690)
28. Mahnke A, Strotkamp D, Roos PH, Hanstein WG, Chabot GG, Nef P. Expression and inducibility of cytochrome P450 3A9 (CYP3A9) and other members of the CYP3A subfamily in rat liver. Arch Biochem Biophys 1997; 337: 62-68. (Pubitemid 27198055)
29. Kim H, Putt DA, Zangar RC, et al. Differential induction of rat hepatic cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in response to pyridine treatment. Drug Metab Dispos 2001; 29: 353-360. (Pubitemid 32179538)
30. Choudhuri S, Zhang XJ, Waskiewicz MJ, Thomas PE. Differential regulation of cytochrome P450 3A1 and P450 3A2 in rat liver following dexamethasone treatment. J Biochem Toxicol 1995; 10: 299-307.
31. Sierra-Santoyo A, Hernández M, Albores A, Cebrián ME. Sex-dependent regulation of hepatic cytochrome P-450 by DDT. Toxicol Sci 2000; 54: 81-87. (Pubitemid 30152458)
32. Guévin C, Michaud J, Naud J, Leblond FA, Pichette V. Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators. Br J Pharmacol 2002; 137: 1039-1046. (Pubitemid 35440744)
33. Michaud J, Dubé P, Naud J, et al. Effects of serum from patients with chronic renal failure on rat hepatic cytochrome P450. Br J Pharmacol 2005; 144: 1067-1077. (Pubitemid 40593005)
34. Ribeiro V, Lechner MC. Cloning and characterization of a novel CYP3A1 allelic variant: analysis of CYP3A1 and CYP3A2 sex-hormone-dependent expression reveals that the CYP3A2 gene is regulated by testosterone. Arch Biochem Biophys 1992; 293: 147-152.
35. Ji L, Masuda S, Saito H, Inui K. Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. Kidney Int 2002; 62: 514-524. (Pubitemid 34779762)
36. Michaud J, Naud J, Chouinard J, et al. Role of parathyroid hormone in the downregulation of liver cytochrome P450 in chronic renal failure. J Am Soc Nephrol 2006; 17: 3041-3048. (Pubitemid 44707764)
37. Abdel-Razzak Z, Loyer P, Fautrel A, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 1993; 44: 707-715. (Pubitemid 23317282)
38. Morgan ET, Thomas KB, Swanson R, Vales T, Hwang J, Wright K. Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. Biochim Biophys Acta 1994; 1219: 475-483. (Pubitemid 24319709)
39. Nadin L, Butler AM, Farrell GC, Murray M. Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor α. Gastroenterology 1995; 109: 198-205.
40. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557. (Pubitemid 32666340)